Download these results as:
| Activity Sort descending | Dosage | Reference |
|---|---|---|
| ACTH-genic | not available | Duke, 1992 * |
| Adenylate-Cyclase-Activator | not available | Merck 11th Edition |
| Adrenergic | not available | Duke, 1992 * |
| Amebicide | 1,000 ug/ml | Recently became Internat. J. Crude Drug Res. 28(1,2,3,4):1990, page 1. |
| Antiaggregant | IC50=6 ug/ml | Duke, 1992 * |
| Antiasthmatic | not available | Duke, 1992 * |
| Antibronchitic | not available | Duke, 1992 * |
| Antiglaucomic | not available | Martindale's 29th |
| Antihistaminic | not available | Duke, 1992 * |
| Antiinflammatory | not available | Duke, 1992 * |
| Antimetastatic | not available | Duke, 1992 * |
| Antimitotic | not available | Duke, 1992 * |
| Antiplatelet | not available | Duke, 1992 * |
| Antipsoriac | not available | Duke, 1992 * |
| Antispasmodic | not available | Duke, 1992 * |
| Antithrombotic | not available | Bezanger-Beauquesne, L. Noveautes en Phytotherapie. Huitieme Revue. Plantes medicinales et phytotherapie, 25: 46-76, 1991. |
| Antithyreotropic | not available | Duke, 1992 * |
| Beta-Adrenergic Receptor Blocker | 1-7 days ivn rat | Suzdak, P. D., Browne, R. G. 1985. The Effect of Chronic in vivo Infusion of Forskolin on Noradrenergic Receptor Sensitivity. Psychopharmacology, 87(4): 464-467. |
| Bronchodilator | not available | Duke, 1992 * |
| cAMP-genic | not available | Duke, 1992 * |